We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Roche Holding Ag | LSE:0QQ6 | London | Ordinary Share | CH0012032113 | ROCHE HOLDING ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 229.20 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
4,506 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 58.72B | 11.5B | - | N/A | 0 |
Date | Time | Source | Headline |
---|---|---|---|
19/4/2024 | 06:00 | UKREG | FDA approves Roche’s Alecensa as the first adjuvant treatment for people.. |
17/4/2024 | 07:00 | UKREG | Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete.. |
15/4/2024 | 06:00 | UKREG | [Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary.. |
11/4/2024 | 06:00 | UKREG | Roche granted FDA Breakthrough Device Designation for blood test to support.. |
26/3/2024 | 16:45 | UKREG | Roche receives FDA approval for the first molecular test to screen for.. |
12/3/2024 | 12:30 | UKREG | Assemblée générale 2024 de Roche |
12/3/2024 | 12:30 | UKREG | Roche Annual General Meeting 2024 |
12/3/2024 | 12:30 | UKREG | Roche Generalversammlung 2024 |
05/3/2024 | 12:30 | UKREG | Roche and Alnylam report positive topline results from the Phase II.. |
25/2/2024 | 19:00 | UKREG | New England Journal of Medicine publishes Phase III data showing Xolair.. |
1 Year Roche Chart |
Intraday Roche Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions